Acute effects of intraperitoneal versus subcutaneous insulin delivery on glucose homeostasis in patients with NIDDM

Diabetes Care

Volumn 19, Issue 11, 1996, Pages 1237-1242

  Kelley, David E ^a,c   Henry, Robert R ^b   Edelman, Steven V ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^c UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACID; GLUCOSE; INSULIN; ISOPHANE INSULIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FATTY ACID BLOOD LEVEL; GLUCONEOGENESIS; GLUCOSE BLOOD LEVEL; GLUCOSE CLAMP TECHNIQUE; GLUCOSE UTILIZATION; HUMAN; INSULIN BLOOD LEVEL; INSULIN PUMP; INTRAPERITONEAL DRUG ADMINISTRATION; ISOTOPE DILUTION ASSAY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; RANDOMIZED CONTROLLED TRIAL; SUBCUTANEOUS DRUG ADMINISTRATION; TREATMENT OUTCOME;

EID: 0029964925     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.19.11.1237     Document Type: Article

References (25)

1. Shade DS, Eaton RP, Davis T, Akiya F, Phinney E, Kubica R, Vaugh FA, Day PW: The kinetics of peritoneal insulin absorption. Metabolism 30:149-155,1981
2. Micossi P, Cristallo M, Librenti MC, Petrella G, Galimberti G, Melandri M, Monti L, Spotti D, Scavini M, DiCarlo y Pozza G: Free-insulin profiles after intraperitoneal, intramuscular, and subcutaneous insulin administration. Diabetes Care 9:575-578, 1986
3. Selam J-L, Bergman RN, Raccah D, Nathalie J-D, Lorzano J, Charles MA: Determination of portal insulin absorption from peritoneum via novel nonisotopic method. Diabetes 39:1361-1365,1990
4. Radziuk J, Pye S, Seigly DE, Skyler JS, Offord F, Davies G: Splanic and systemic absorption of intraperitoneal insulin a new double-tracer method. Am J Physiol 266 (Endocnnol Metal 29):E750-E759,1994
5. Saudek CD, Selam J-L, Pitt HA, Waxman K, Rubio M, Jeandidier N, Turner D, Fischell RE, Charles MA: A preliminary trial of the programmable implantable medication system for insulin delivery. N Engl J Med 321:574-579,1989
6. Selam J-L, Raccah D, Jean-Didier N, Lozano JL, Waxman K, Charles MA: Randomized comparison of metabolic control achieved by intraperitoneal insulin infusion with implantable pumps versus intensive subcutaneous insulin therapy in type I diabetic patients. Diabetes Care 15:53-58, 1992
7. Saudek CD and the Implantable Insulin Pump Study Group: Comparison of implantable insulin pumps with multiple dose insulin in the treatment of noninsulin-dependent diabetes mellitus: the Veterans Affairs Implantable Insulin Pump Study. Diabetes 43 (Suppl. 1):61A, 1994
8. Shishko PI, Kovalev PA, Goncharov VG, Zajamy IU: Comparison of peripheral and portal (via the umbilical vein) routes of insulin infusion in IDDM patients. Diabetes 41:1042-1049, 1992
9. Monti LD, Piatti PM, Home PD, Tomson C, Alberti KGMM: The effect of intraperitoneal insulin delivery on carbohydrate metabolism in type I (insulin-dependent) diabetic patients. Diabetes Res Cfin Pract 15:237-244, 1992
10. Finegood D, Bergman R, Vranic M: Modeling error and apparent isotope discrimination confound estimation of endogenous glucose production during euglycemic glucose clamps. Diabetes 37:1025-1034,1988
11. Kelley D, Reilly J, Veneman T, Mandarino L: The influence of physiologic hyperinsulinemia on skeletal muscle glucose storage, oxidation and glycolysis in man. Am J Physiol 258:E923-E929,1990
12. Morgan CR, Lazarow A: Immunoassay of insulin: two antibody system: plasma insulin levels of normal, subdiabetic, and diabetic rats. Diabetes 12:115-126, 1993
13. Faber OK, Binder C, Markussen J, Heding LG, Naithani VK, Kuzuta H, Bliz P, Horwitz DL, Rubenstein AH: Characterization of seven C-peptide antisera. Diabetes 27 (Suppl. 1):170-177,1978
14. Binder C, Lauritzen T, Faber O, Prammino S: Insulin pharmacokinetics: a review. Diabetes Care 7:188-199, 1984
15. Clauson PG, Linde B: Absorption of rapidacting insulin in obese and nonobese NIDDM patients. Diabetes Care 18:986-991,1995
16. Campbell PJ, Mandarino LJ, Gerich JE: Quantification of the relative impairment in actions of insulin on hepatic glucose production and peripheral glucose uptake in non-insulin dependent diabetes melli-tus. Metabolism 37:15-21,1988
17. DeFronzo RA: Lilly lecture 1987: The triumvirate: B-cell, muscle, liver: a collusion responsible for NIDDM. Diabètes 37:667-687,1988
18. Olefsky J: Pathogenesis of insulin resistance and hyperglycemia in non-insulin dependent diabetes mellitus. Am J Med 75:1-7,1985
19. Bratusch-Marrain PR, Komjati M, Waldhâusl WK: Efficacy of pulsatile versus continuous insulin administration on hepatic glucose production and glucose utilization in type I diabetic humans. Diabetes 35:922-926,1985
20. Fanelli C, Calderone S, Epifano L, DeVincenzo A, Modarelli F, Pampanelli S, Perriello G, DeFeo P, Brunetti P, Gerich JE, Bolli GB: Demonstration of a critical role for free fatty acid in mediating counter regulatory stimulation of gluconeogenesis and suppression of glucose utilization in humans. J Clin Invest 92:1617-1622, 1993
21. Botz CK, Leibel BS, Zingg W, Gander RE, Albisser AM: Comparison of peripheral and portal rates of insulin infusion by a computer-controlled insulin infusion system (artificial endocrine pancreas). Diabetes 25:691-700,1976
22. Ishida T, Chap Z, Chou J, Lewis RM, Hartley CJ, Entman ML, Field JB: Effects of portal and peripheral venous insulin infusion on glucose production and utilization in depancreatized conscious dogs. Diabetes 33:984-990,1984
23. Kryshak EJ, Butler PD, March C, Miller A, Barr D, Polonsky K, Perkins JD, Rizza RA: Pattern of postprandial carbohydrate metabolism and effects of portal and peripheral insulin delivery. Diabetes 39:142-148, 1990
24. Lewis GF; Zinman B, Uffelman KD, Szeto L, Weller B, Steiner G: VLDL production is decreased to a similar extent by acute portal vs. peripheral venous insulin. Am J Physio! 267 (Endocrinol Metab 30):E566-E572,1994
25. Brange J, Owens DR, Kang S, Volund A: Monomeric insulins and their experimental and clinical implications. Diabetes Care 13:923-954,1990